MarketPeel
Insider Trading Intelligence
CS

Catherine A. Sohn

JAZZ
DIRECTOR · JAZZ PHARMACEUTICALS PLC · CIK 0001555132
FILING MIX · LIFETIME59%/41%
BUYS
20
SELLS
14
TOTAL VALUE
$4.77M
COMPANIES
3
ACTIVE SINCE
Aug 2020
HOLDINGS NOW
87,307
AVG SELL PX
$79.92
TRADE KIND
SHOWING 34 / 34
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizons · 9 pending
Forward-return performance of every backtestable P/S trade by Catherine A. Sohn, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+42.86%+0.23%+2.07%-1.84%-0.19%
14d7+42.86%-0.57%+0.33%-0.90%+2.05%
30d7+57.14%+2.20%+0.35%+1.85%+2.31%
60d7+14.29%+0.07%+0.32%-0.25%-5.86%
90d7+85.71%-9.07%+1.24%-10.31%-11.57%
180d7(2 pending)+0.00%-10.17%+14.12%-24.29%-17.69%
1y7(3 pending)+75.00%-21.33%+26.18%-47.51%-52.96%
2y7(4 pending)+100.00%-13.67%+18.33%-32.01%-19.71%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
JAZZ · 14,868 shares · as of Aug 14, 2023
04,6569,31113,96718,622202120222023SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 20 buys / 14 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ALT
ALTIMMUNE, INC.
PURCHASEGRANT
Stock grant
48,80048,800May 1, 2026May 1, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
SALE
2,895316Jan 7, 2026Jan 8, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
SALE
26,920$39.11$1.05M0Jan 7, 2026Jan 8, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASE
3,281$10.42$34.2K26,920Jan 7, 2026Jan 8, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASE
20,744$10.42$216.2K20,744Jan 7, 2026Jan 8, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
SALE
3,2815,805Jan 7, 2026Jan 8, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
SALE
20,7440Jan 7, 2026Jan 8, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASE
2,895$10.42$30.2K23,639Jan 7, 2026Jan 8, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASE
2,493$10.42$26.0K2,493Jan 6, 2026Jan 8, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
SALE
2,493$38.62$96.3K0Jan 6, 2026Jan 8, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
SALE
2,4933,211Jan 6, 2026Jan 8, 2026View →
ALT
ALTIMMUNE, INC.
PURCHASE
500$4.24$2.1K1,500Jan 5, 2026Jan 5, 2026View →
ALT
ALTIMMUNE, INC.
PURCHASEGRANT
Stock grant
48,80048,800Sep 25, 2025Sep 29, 2025View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
18,00018,000Sep 22, 2025Sep 24, 2025View →
ALT
ALTIMMUNE, INC.
PURCHASE
1,000$5.78$5.8K1,000Mar 17, 2025Mar 18, 2025View →
ALT
ALTIMMUNE, INC.
PURCHASEGRANT
Stock grant
18,60018,600Feb 6, 2025Feb 7, 2025View →
ALT
ALTIMMUNE, INC.
PURCHASEGRANT
Stock grant
34,90034,900Sep 26, 2024Sep 30, 2024View →
ALT
ALTIMMUNE, INC.
PURCHASEGRANT
Stock grant
26,10026,100Sep 28, 2023Sep 29, 2023View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
1,241$138.16$171.5K14,868Aug 14, 2023Aug 15, 2023View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
3,07516,109Aug 11, 2023Aug 15, 2023View →
ALT
ALTIMMUNE, INC.
PURCHASEGRANT
Stock grant
47,00047,000Mar 23, 2023Mar 27, 2023View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
1,089$152.32$165.9K13,034Aug 8, 2022Aug 9, 2022View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
2,56114,123Aug 5, 2022Aug 9, 2022View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
1,306$147.96$193.2K11,562Aug 6, 2021Aug 10, 2021View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
2,24612,868Jul 29, 2021Aug 2, 2021View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
8,000$152.00$1.22M10,622Nov 4, 2020Nov 6, 2020View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
4,500$156.00$702.0K10,622Nov 4, 2020Nov 6, 2020View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASE
4,500$81.76$367.9K15,122Nov 4, 2020Nov 6, 2020View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
4,5000Nov 4, 2020Nov 6, 2020View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASE
8,000$46.83$374.6K18,622Nov 4, 2020Nov 6, 2020View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
8,0000Nov 4, 2020Nov 6, 2020View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
931$125.87$117.2K10,622Aug 7, 2020Aug 10, 2020View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
6,7656,765Aug 6, 2020Aug 10, 2020View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
2,70511,553Aug 6, 2020Aug 10, 2020View →
Other insiders · JAZZ
Loading peer insiders…
About this filer
CIK 0001555132
ROLE
Director
PRIMARY
JAZZ
COMPANIES
3
ACTIVE SINCE
Aug 2020
MARKETPEEL · /INSIDER/0001555132DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback